RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CTT Pharmaceutical Holdings Stock

CTT Pharmaceutical Holdings Equity 2024

CTT Pharmaceutical Holdings Equity

0 USD

Ticker

CTTH

ISIN

US12651E1064

WKN

A14ZP5

In 2024, CTT Pharmaceutical Holdings's equity was 0 USD, a 0% increase from the 0 USD equity in the previous year.

CTT Pharmaceutical Holdings Aktienanalyse

What does CTT Pharmaceutical Holdings do?

CTT Pharmaceutical Holdings Inc. is a leading company in the pharmaceutical industry specializing in the development, manufacturing, and marketing of various cannabis-based products. It was founded in 2007 as a research company focused on the medical applications of cannabis. In 2014, the company received patents for their revolutionary platform technology for delivering cannabinoids through lozenges. CTT's business model is based on the development and commercialization of patented delivery systems for cannabinoids, primarily focusing on lozenges. It has subsidiaries and joint ventures in countries like the US, Mexico, and Australia. CTT aims to be a leading provider of cannabinoid-based medicines, with a focus on pain management, neurological disorders, and cancer treatment. Some of their key products include CannavertTM for chemotherapy-induced nausea and vomiting, OraldissTM for neurological conditions like epilepsy and Parkinson's disease, and AnesthevertTM for acute and chronic pain management. CTT collaborates with other pharmaceutical companies and research institutions to market their products and improve their technology. CTT Pharmaceutical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing CTT Pharmaceutical Holdings's Equity

CTT Pharmaceutical Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding CTT Pharmaceutical Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating CTT Pharmaceutical Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

CTT Pharmaceutical Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in CTT Pharmaceutical Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about CTT Pharmaceutical Holdings stock

What is the equity of CTT Pharmaceutical Holdings this year?

CTT Pharmaceutical Holdings has equity of 0 USD this year.

What was the equity of CTT Pharmaceutical Holdings compared to the previous year?

The equity of CTT Pharmaceutical Holdings has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of CTT Pharmaceutical Holdings?

A high equity is advantageous for investors of CTT Pharmaceutical Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of CTT Pharmaceutical Holdings?

A low equity can be a risk for investors of CTT Pharmaceutical Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of CTT Pharmaceutical Holdings affect the company?

An increase in equity of CTT Pharmaceutical Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of CTT Pharmaceutical Holdings affect the company?

A reduction in equity of CTT Pharmaceutical Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of CTT Pharmaceutical Holdings?

Some factors that can affect the equity of CTT Pharmaceutical Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of CTT Pharmaceutical Holdings so important for investors?

The equity of CTT Pharmaceutical Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can CTT Pharmaceutical Holdings take to change the equity?

To change equity, CTT Pharmaceutical Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does CTT Pharmaceutical Holdings pay?

Over the past 12 months, CTT Pharmaceutical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CTT Pharmaceutical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of CTT Pharmaceutical Holdings?

The current dividend yield of CTT Pharmaceutical Holdings is .

When does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings paid dividends every year for the past 0 years.

What is the dividend of CTT Pharmaceutical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CTT Pharmaceutical Holdings located?

CTT Pharmaceutical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von CTT Pharmaceutical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CTT Pharmaceutical Holdings from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did CTT Pharmaceutical Holdings pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of CTT Pharmaceutical Holdings in the year 2023?

In the year 2023, CTT Pharmaceutical Holdings distributed 0 USD as dividends.

In which currency does CTT Pharmaceutical Holdings pay out the dividend?

The dividends of CTT Pharmaceutical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CTT Pharmaceutical Holdings

Our stock analysis for CTT Pharmaceutical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTT Pharmaceutical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.